Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Japanese approval for Hepsera

Oct. 29, 2004

Improved nucleoside triphosphate analogue promising against HCV infection

Oct. 27, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Glycine may represent a novel eradication therapy against drug-resistant H. pylori

Oct. 26, 2004

New HCV studies unveiled for PegIntron in difficult-to-treat populations

Oct. 26, 2004

Japanese approval for PegIntron in combination with Rebetol

Oct. 26, 2004

Positive opinion for Fendrix in Europe

Oct. 26, 2004

Dual opioid receptor agonist JNJ-10335572 shows good activity in in vivo GI assays

Oct. 25, 2004

GSK patent covers new anti-HCV NS5B inhibitors

Oct. 20, 2004

Biofrontera presents a novel antibiotic with anti-H. pylori activity

Oct. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.